Novel targets for the pharmacotherapy of diarrhoea: a view for the millennium (Q34095689)

31 July 2017

1 reference

title

Novel targets for the pharmacotherapy of diarrhoea: a view for the millennium (English)

1 reference

31 July 2017

0 references

0 references

Farthing MJ

1

1 reference

31 July 2017

1 October 2000

1 reference

Journal of Gastroenterology and Hepatology

31 July 2017

1 reference

31 July 2017

15 Suppl

1 reference

31 July 2017

G38-45

1 reference

Intestinal electrolyte transport and diarrheal disease (2)

31 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02264.X

Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02264.X

Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02264.X

Release of vasoactive intestinal polypeptide from the cat small intestine exposed to cholera toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02264.X

Prostaglandin E2 is a mediator of 5-hydroxytryptamine induced water and electrolyte secretion in the human jejunum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02264.X

5-hydroxytryptamine release into human jejunum by cholera toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02264.X

Inhibition of cholera toxin-induced intestinal secretion by the 5-HT3 receptor antagonist ICS 205-930.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02264.X

Role of 5-hydroxytryptamine type 3 receptors in rat intestinal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02264.X

Role of nitric oxide in intestinal water and electrolyte transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02264.X

L-Arginine, nitric oxide, and intestinal secretion: studies in rat jejunum in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02264.X

The enteric nervous system participates in the secretory response to the heat stable enterotoxins of Escherichia coli in rats and cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02264.X

CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02264.X

Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02264.X

The sigma ligand, igmesine, inhibits cholera toxin and Escherichia coli enterotoxin induced jejunal secretion in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02264.X

The role of somatostatin analogues in the treatment of refractory diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02264.X

Octreotide in the treatment of refractory diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02264.X

Racecadotril demonstrates intestinal antisecretory activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2000.02264.X

10.1046/J.1440-1746.2000.02264.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11100992